These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 3753096)

  • 21. Azaperone, a sedative neuroleptic of the butyrophenone series with pronounced anti-aggressive and anti-shock activity in animals.
    Niemegeers CJ; Van Nueten JM; Janssen PA
    Arzneimittelforschung; 1974 Nov; 24(11):1798-1806. PubMed ID: 4480053
    [No Abstract]   [Full Text] [Related]  

  • 22. [Behavioral effects of flutoprazepam (KB-509) and its metabolites].
    Ueki S; Sukamoto T; Watanabe S; Yamamoto T; Kataoka Y; Shibata S; Suwandi D; Shibata K; Takano M; Sato Y
    Nihon Yakurigaku Zasshi; 1982 Jul; 80(1):15-30. PubMed ID: 6890927
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological properties of substituted gamma-butyrolactones. I. The effects on the central nervous system.
    Sieroslawska J; Hano J; Sypniewska M; Czarnecki R; Chojnacka-Wójcik E; Harasiewicz A
    Pol J Pharmacol Pharm; 1973; 25(1):1-16. PubMed ID: 4798097
    [No Abstract]   [Full Text] [Related]  

  • 24. [Behavioral effects of amantadine on ambulatory activity and drinking in mice and on continuous and discrete avoidance responses in rats].
    Kuribara H; Tadokoro S
    Nihon Yakurigaku Zasshi; 1984 Feb; 83(2):147-58. PubMed ID: 6745805
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of aqueous and lipid-soluble extracts of kava on the conditioned avoidance response in rats.
    Duffield PH; Jamieson DD; Duffield AM
    Arch Int Pharmacodyn Ther; 1989; 301():81-90. PubMed ID: 2624519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of raclopride and haloperidol on spontaneous motor activity and on conditioned avoidance behavior in rats. A comparison of potency, efficacy and time-course of action.
    Wadenberg ML; Ahlenius S
    Arzneimittelforschung; 1991 Jul; 41(7):692-5. PubMed ID: 1772455
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The influence of NMDA, a potent agonist of glutamate receptor, on behavioral activity of rats with experimental hyperammonemia evoked by liver failure.
    Fedosiewicz-Wasiluk M; Hoły ZZ; Wiśniewska RJ; Wiśniewski K
    Amino Acids; 2005 Feb; 28(1):111-7. PubMed ID: 15700110
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuropharmacological profile of MD 790501, a new benzamide derivative.
    Jalfre M; Bucher B; Dorme N; Mocquet G; Porsolt RD
    Arch Int Pharmacodyn Ther; 1983 Aug; 264(2):232-56. PubMed ID: 6139097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DuP 734 [1-(cyclopropylmethyl)-4-(2'(4''-fluorophenyl)-2'- oxoethyl)piperidine HBr], a potential antipsychotic agent: preclinical behavioral effects.
    Cook L; Tam SW; Rohrbach KW
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1159-66. PubMed ID: 1361571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Behavioral, biochemical, and pharmacological effects of chronic dosage of phenothiazine tranquilizers in rats.
    Maickel RP; Braunstein MC; McGlynn M; Snodgrass WR; Webb RW
    Adv Biochem Psychopharmacol; 1974; 9(0):593-602. PubMed ID: 4836224
    [No Abstract]   [Full Text] [Related]  

  • 31. Central activity of 2-amino-4-phosphonobutyric acid (AP4).
    Zalewska A; Winnicka MM; Wiśniewski K
    Pol J Pharmacol; 1995; 47(1):9-17. PubMed ID: 7550555
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A scatter-jump syndrome with gnawing and fighting induced by L-dopa in mice.
    Bryson G; Bischoff F
    Res Commun Chem Pathol Pharmacol; 1971; 2(4):469-76. PubMed ID: 5167776
    [No Abstract]   [Full Text] [Related]  

  • 33. Some behavioral effects of microinjections of noradrenaline and serotonin into the hippocampus of the rat.
    Płaźnik A; Danysz W; Kostowski W
    Physiol Behav; 1983 Nov; 31(5):625-31. PubMed ID: 6320239
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The effect of diazepam on fetal development].
    Liubimov BI; Smol'nikova NM; Strekalova SN
    Biull Eksp Biol Med; 1974 Oct; 78(10):64-6. PubMed ID: 4461124
    [No Abstract]   [Full Text] [Related]  

  • 35. Pharmacological profiles in rats of novel antipsychotics with combined dopamine D2/serotonin 5-HT1A activity: comparison with typical and atypical conventional antipsychotics.
    Bardin L; Auclair A; Kleven MS; Prinssen EP; Koek W; Newman-Tancredi A; Depoortère R
    Behav Pharmacol; 2007 Mar; 18(2):103-18. PubMed ID: 17351418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Muricidal block induced by 5-hydroxytryptophan in the rat.
    Kulkarni AS; Rahwan RG; Bocknik SE
    Arch Int Pharmacodyn Ther; 1973 Feb; 201(2):308-13. PubMed ID: 4541981
    [No Abstract]   [Full Text] [Related]  

  • 37. Synthesis and preliminary pharmacology of a novel butyrophenone derivative, ID-4708.
    Honma T; Sasajima K; Ono K; Kitagawa S; Inaba S; Yamamoto H
    Arzneimittelforschung; 1974 Sep; 24(9):1248-56. PubMed ID: 4479786
    [No Abstract]   [Full Text] [Related]  

  • 38. Cardiovascular effect of skimmianine in rats.
    Cheng JT; Chang SS; Chen IS
    Arch Int Pharmacodyn Ther; 1990; 306():65-74. PubMed ID: 2076049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of chlorpromazine on two types of conditioned avoidance behavior.
    Dobrin PB; Rhyne RL
    Arch Int Pharmacodyn Ther; 1969 Apr; 178(2):351-6. PubMed ID: 5355566
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacological properties of new neuroleptic compounds.
    Coscia L; Causa P; Giuliani E; Nunziata A
    Arzneimittelforschung; 1975 Sep; 25(9):1436-42. PubMed ID: 25
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.